READNOUR ROBIN SHANE sold 2.5% of their position (16.12K shares) of AN2 THERAPEUTICS, INC. on the open market
Open‑market sale worth $97.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/8/2026ACC: 0001193125-26-385511
Director
Since Mar 2022
-16.12K
Net shares
Net seller
$97.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
16.12K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.88K
Price / share
$6.07
Trade value
$17.46K
% of position
0.5%
9/3/2026
565.59K→562.72K
Common Stock
Indirect
Shares
−3.22K
Price / share
$6.07
Trade value
$19.56K
% of position
0.5%
9/3/2026
633.87K→630.64K
Common Stock
Indirect
Shares
−4.72K
Price / share
$6.02
Trade value
$28.44K
% of position
0.8%
9/8/2026
562.72K→557.99K
Common Stock
Indirect
Shares
−5.29K
Price / share
$6.02
Trade value
$31.86K
% of position
0.8%
9/8/2026
630.64K→625.35K
Total
Net shares
−16.12K
Net value
-$97.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/3/2026 | S · Sale | −2.88K | $6.07 | $17.46K | 0.5% | 565.59K | 562.72K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −3.22K | $6.07 | $19.56K | 0.5% | 633.87K | 630.64K |
| Common Stock Indirect | 9/8/2026 | S · Sale | −4.72K | $6.02 | $28.44K | 0.8% | 562.72K | 557.99K |
| Common Stock Indirect | 9/8/2026 | S · Sale | −5.29K | $6.02 | $31.86K | 0.8% | 630.64K | 625.35K |
| Total | −16.12K | -$97.32K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned9.08K
Total
9.08K direct9.08K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.08K | Direct |
| Total | 9.08K | 9.08K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported